Additionally, post-mortem studies on patients with schizophrenia have highlighted altered astrocytic activity, reporting significant changes in astrocyte morphology, density, and dysregulated expression of astrocyte-defining cellular markers associated with a significant increase in the levels of glial fibrillary acidic protein (GFAP) [57,58]. This evidence concerns the gene GFAP and schizophrenia.